Monday, 28 September 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Godavari Drugs Ltd

NSE: GODAVARI · BSE: 530317 · Pharmaceuticals & Biotechnology · 3 announcements

Share price: ₹125.18
Market cap: ₹126.8 Cr
Revenue (annual): ₹105.8 Cr
Net profit (annual): ₹4.09 Cr
P/E (TTM): 30.5×Sector 50.4×
Promoter holding: 40.23%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 2 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

14 Aug 2026 12:55 IST BSE

Financial Results

Godavari Drugs Q1 FY27 Results: Net Profit ₹1.1 Cr, Up 10.0% YoY

Godavari Drugs Ltd reported revenue from operations of ₹28 Cr (+17.6% YoY) and net profit of ₹1.1 Cr (+10.0% YoY) for Q1 FY27.

Key figure: Net profit ₹1.1 Cr · +10.0% YoY

Open full results → Read the filing ↗

27 May 2026 16:48 IST BSE

Financial Results

Godavari Drugs Q4 FY26 Results: Net Profit ₹1.3 Cr, Up 44.4% YoY

Godavari Drugs Ltd reported revenue from operations of ₹33.2 Cr (+30.2% YoY) and net profit of ₹1.3 Cr (+44.4% YoY) for Q4 FY26.

Key figure: Net profit ₹1.3 Cr · +44.4% YoY

Open full results → Read the filing ↗